Our pioneering SomaScan® Assay is a game changer for your oncology research
Accelerate your biomarker discovery with sensitive detection of 7,000 proteins from a 55-μL sample
The SomaScan Assay is designed for sensitivity and specificity to detect low-abundant proteins, such as cytokines, to lead to your next breakthrough discovery.
The SomaScan Assay Empowers Discovery
Diagnostic
Identify unique cancer-specific protein biomarkers for future diagnostic indicators
Prognostic
Monitor proteins over time for markers indicative of disease progression/regression
Predictive
Reveal proteins that correlate with a cancer event for development of preventive measures
Stratification
Define protein signatures that correlate with specific subtypes, for use in therapeutic development
Also available: SomaScan Panels for targeted data:
Oncology
863 analytes
863 analytes
Cytokines
168 analytes
168 analytes
